Merkel Cell Carcinoma Market Research Report - Global Forecast till 2027

Global Merkel Cell Carcinoma Market Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2027

ID: MRFR/Pharma/3900-HCR | | Region: Global | 90 pages

Market Scenario


Merkel cell carcinoma is a rare and aggressive type of skin cancer with a high risk of recurrence and metastasis. Most recurrences occur within two years after the diagnosis of the primary tumor. The main cause of the disease is Merkel cell polyomavirus (MCV). Majority of the geriatric population is affected by the disease. Moreover, the risk of developing the disease increases with long exposure to the sun. Thus, factors like increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. According to a study published in the Current Dermatology Reports journal in 2014, the annual incidence of MCC was 0.6 per 100,000 people. Moreover, according to the United Nations Population Fund, the total geriatric population is expected to increase from 12.3% of the global population in 2016 to 22.0% of the global population by 2050. Moreover, increasing expenditure in R&D by the key market players, rising mortality rate by MCC, and growing healthcare expenditure are some of the factors that boost the market growth during the forecast period. However, the high cost of therapeutics and related side effects, lack of awareness, and low per capita healthcare expenditures in the middle and low-income countries is estimated to restrain the market growth during the forecast period.


 


The global Merkel cell carcinoma market is expected to grow at a CAGR of 7.40% during forecast period.


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1: Global Merkel Cell Carcinoma Market Share, by Region Merkel Cell Carcinoma Market


Sources: United Nations Population Fund, American Cancer Society, Cancer Research UK, WHO, annual reports, press release, white paper, and company presentation


Segmentation


The global Merkel cell carcinoma market is segmented on the basis of diagnosis, treatment, and end users. On the basis of the diagnosis, the market is categorized into physical examination, sentinel node biopsy, imaging tests, and others. The imaging tests segment is sub-segmented into X-ray, computed tomography (CT), positron emission tomography (PET), and others. On the basis of the treatment, the market is segmented into surgery, radiation therapy, chemotherapy, and others. The chemotherapy segment is sub-segmented into etoposide, cisplatin, and others. On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic centers, research organization, and others.


Key players in the global Merkel cell carcinoma market


Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), OncoSec Medical Incorporated (U.S.), Bristol-Myers Squibb Company (U.S.), General Electric Company (U.S.), Siemens Medical Solutions USA, Inc. (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), Philips Health Care (The Netherlands), AstraZeneca (U.K), Mediso Ltd. Endomagnetics Limited (Hungary), and others are some of the major players in the global Merkel cell carcinoma market.


Research Methodology


Merkel Cell Carcinoma Market 2018


Sources: Sources: United Nations Population Fund, American Cancer Society, Cancer Research UK, WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


The Americas dominate the global Merkel cell carcinoma market owing to the presence of developed economies like the U.S. and Canada, a well-developed healthcare sector and high per capita healthcare expenditures. Moreover, the presence of the major market players within the region boosts the market growth.


Europe is the second largest Merkel cell carcinoma market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, and government support for research & development is estimated to drive the market growth within the region. Apart from this, increasing number of patients suffering from skin cancer provides favorable backgrounds for market growth within the region. According to the Cancer Research U.K, 15,906 new cases of melanoma cancer were diagnosed in 2015, within the region.


Asia Pacific is the fastest growing region for the market due to the presence of economies like India, Australia, and China along with the presence of developing healthcare sector in the market. Increasing prevalence of skin cancer, growing geriatric population, and rising healthcare expenditure boost the market growth within the region.


On the other hand, the Middle East & Africa has the least share in the Merkel cell carcinoma market due to the presence of poor economies and stringent government policies, especially in the African region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the developed economies like Qatar, Dubai and others.



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Global Merkel cell carcinoma market is expected to expand at 7.40% CAGR from 2017 to 2023.

Rising prevalence of Merkel cell carcinoma is the primary driver of the Merkel cell carcinoma market.

Side effects of treatment, lack of awareness among patients, and low healthcare expenditure are major factors which can impede the global Merkel cell carcinoma market growth.

The Americas is expected to dominate the global Merkel cell carcinoma market till 2023.

OncoSec Medical Incorporated, Merck & Co., Inc., Pfizer Inc., CANON MEDICAL SYSTEMS CORPORATION, Siemens Medical Solutions USA, Inc., Philips Health Care, Mediso Ltd., Endomagnetics Limited, Bristol-Myers Squibb Company, AstraZeneca, and General Electric Company are prominent players of the global Merkel cell carcinoma market.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Merkel Cell Carcinoma Market, by Diagnosis

6.1 Introduction

6.2 Physical Examination

Market Estimates & Forecast, 2020 – 2027

6.3 Sentinel Node Biopsy

Market Estimates & Forecast, 2020 – 2027

6.4 Imaging Tests

Market Estimates & Forecast, 2020 – 2027

6.4.1 X-ray

6.4.2 Computed Tomography (CT)

6.4.3 Positron Emission Tomography (PET)

6.4.4 Others

6.5 Others

Chapter 7. Global Merkel Cell Carcinoma Market, by Treatment

7.1 Introduction

7.2 Surgery

Market Estimates & Forecast, 2020 – 2027

7.3 Radiation Therapy

Market Estimates & Forecast, 2020 – 2027

7.4 Chemotherapy

Market Estimates & Forecast, 2020 – 2027

7.4.1 Etoposide

7.4.2 Cisplatin

7.4.3 Others

7.5 Others

Chapter 8 Global Merkel Cell Carcinoma Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, 2020 – 2027

8.3 Diagnostic Centers

Market Estimates & Forecast, 2020 – 2027

8.4 Research Organizations

Market Estimates & Forecast, 2020 – 2027

8.5 Others

Chapter 9. Global Merkel Cell Carcinoma Market, by Region

9.1 Introduction

9.2 The Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview \

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Merck & Co., Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 OncoSec Medical Incorporated

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bristol-Myers Squibb Company

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 General Electric Company

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Siemens Medical Solutions USA, Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 CANON MEDICAL SYSTEMS CORPORATION

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Philips Health Care

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 AstraZeneca

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Mediso Ltd. Endomagnetics Limited

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Merkel Cell Carcinoma Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Merkel Cell Carcinoma Synopsis, 2020 – 2027

Table 2 Global Merkel Cell Carcinoma Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Merkel Cell Carcinoma Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 5 Global Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 6 Global Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 7 North America Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 8 North America Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 9 North America Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 10 U.S. Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 11 U.S. Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 12 U.S. Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 13 Canada Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 14 Canada Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 15 Canada Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 16 South America Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 17 South America Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 18 South America Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 19 Europe Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 20 Europe Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 21 Europe Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 22 Western Europe Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 23 Western Europe Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 24 Western Europe Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Merkel Cell Carcinoma Market by Diagnosis, 2020 – 2027, (USD Million)

Table 32 Middle East & Africa Merkel Cell Carcinoma Market by Treatment, 2020 – 2027, (USD Million)

Table 33 Middle East & Africa Merkel Cell Carcinoma Market by End User, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Merkel Cell Carcinoma Market

Figure 3 Market Dynamics for Global Merkel Cell Carcinoma Market

Figure 4 Global Merkel Cell Carcinoma Market Share, by Diagnosis 2020

Figure 5 Global Merkel Cell Carcinoma Market Share, by Treatment 2020

Figure 6 Global Merkel Cell Carcinoma Market Share, by End User, 2020

Figure 7 Global Merkel Cell Carcinoma Market Share, by Region, 2020

Figure 8 North America Merkel Cell Carcinoma Market Share, by Country, 2020

Figure 9 Europe Merkel Cell Carcinoma Market Share, by Country, 2020

Figure 10 Asia Pacific Merkel Cell Carcinoma Market Share, by Country, 2020

Figure 11 Middle East & Africa Merkel Cell Carcinoma Market Share, by Country, 2020

Figure 12 Global Merkel Cell Carcinoma Market: Company Share Analysis, 2020 (%)

Figure 13 Pfizer Inc.: Key Financials

Figure 14 Pfizer Inc.: Segmental Revenue

Figure 15 Pfizer Inc.: Geographical Revenue

Figure 16 Merck & Co., Inc.: Key Financials

Figure 17 Merck & Co., Inc.: Segmental Revenue

Figure 18 Merck & Co., Inc.: Geographical Revenue

Figure 19 OncoSec Medical Incorporated: Key Financials

Figure 20 OncoSec Medical Incorporated: Segmental Revenue

Figure 21 OncoSec Medical Incorporated: Geographical Revenue

Figure 22 Bristol-Myers Squibb Company: Key Financials

Figure 23 Bristol-Myers Squibb Company: Segmental Revenue

Figure 24 Bristol-Myers Squibb Company: Geographical Revenue

Figure 25 General Electric Company: Key Financials

Figure 26 General Electric Company: Segmental Revenue

Figure 27 General Electric Company: Geographical Revenue

Figure 28 Siemens Medical Solutions USA, Inc. : Key Financials

Figure 29 Siemens Medical Solutions USA, Inc.: Segmental Revenue

Figure 30 Siemens Medical Solutions USA, Inc.: Geographical Revenue

Figure 31 CANON MEDICAL SYSTEMS CORPORATION: Key Financials

Figure 32 CANON MEDICAL SYSTEMS CORPORATION: Segmental Revenue

Figure 33 CANON MEDICAL SYSTEMS CORPORATION: Geographical Revenue

Figure 34 Philips Health Care: Key Financials

Figure 35 Philips Health Care: Segmental Revenue

Figure 36 Philips Health Care: Geographical Revenue

Figure 37 AstraZeneca: Key Financials

Figure 38 AstraZeneca: Segmental Revenue

Figure 39 AstraZeneca: Geographical Revenue

Figure 40 Mediso Ltd. Endomagnetics Limited: Key Financials

Figure 41 Mediso Ltd. Endomagnetics Limited: Segmental Revenue

Figure 42 Mediso Ltd. Endomagnetics Limited: Geographical Revenue